Free Initial Consultation
Local:
636-530-9199
Toll Free:
866-585-4570
defective drug attorneys st louis

Birth control pills subject of nearly 10,000 lawsuits

Birth control pills subject of nearly 10,000 lawsuits

On behalf of Greg Roberts of The Roberts Law Firm, P.C. posted in Defective Drugs on Tuesday, September 10, 2013.

Oral contraceptives are extremely commonly prescribed and typically considered to be safe for use. For decades, women in St. Louis and around the country have counted on these medications for birth control as well as hormonal balancing. Despite the list of precautions and potential side effects listed, much of the time, birth control pills are able to be taken and used without problem.

Unfortunately, that is not always the case. Bayer Pharmaceuticals, the maker of two brands of oral contraceptives that are currently the subject of multiple lawsuits, faces a continued string of such suits. Statistics estimate that there are roughly 10,000 cases nationwide claiming that Yaz and Yasmin are essentially defective drugs, causing a host of physical problems for the women who take them.

The side effects associated with Yaz and Yasmin are primarily related to the body’s blood clotting ability. Cases of stroke, deep vein thrombosis and pulmonary embolisms have been reported. Some women have reported gall bladder complications and even removal. A national attorney network, Resource4the People, continues to offer free consultations to women who believe they may have been the victim of side effects of Yaz or Yasmin. In February 2013, Bayer settled nearly 4,800 such suits with no admission of liability.

Drug safety is a critical factor in public health and pharmaceutical liability should be taken seriously. If you believe that you have been the victim of a drug injury, you may wish to schedule a consultation with an attorney to learn your rights and understand the laws in this area.

Source: Long Island Newsday, “Yaz, Yasmin Lawsuits Allegations Help: Resource4thePeople reports Important Court Hearing Scheduled in Consolidated Federal Cases,” August 28, 2013

Tags: defective drug

Related Posts: FDA drug monitoring and reporting under scrutiny, Proposed bill would allow FDA to regulate dietary supplements, ‘Natural’ not always better in the world of drugs and supplements, Bladder cancer among alleged side effects of diabetes drug

Tags:

Privacy Policy | Business Development Solutions by FindLaw, a Thomson Reuters business.